Myomar Molecular
PrivateLast Round
Seed
May 11, 2026
Total Funding Raised
$4.51M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Myomar Molecular operates in Healthcare & Life Sciences and is based in Halifax, Nova Scotia. Its latest recorded funding round was a Seed round in May 2026.
Myomar Molecular is a biotechnology company that is developing a panel of blood tests to detect and monitor muscle loss (atrophy).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myomar Molecular Comparables
Compare Myomar Molecular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyoCorps | 78% | |
| Biobytes | 69% | |
| InsideTracker | 54% |
For institutional investors. Book with your work email.
Myomar Molecular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 11, 2026 | ||||
| Grant | May 11, 2026 | ||||
| Pre Seed | Mar 1, 2024 | ||||
| Convertible Debt | Feb 7, 2023 |
For institutional investors. Book with your work email.
Myomar Molecular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Ontario Angels | Seed |
| Government of Canada | Pre Seed |
| Women's Equity Lab | Pre Seed |
| Government of Nova Scotia | Pre Seed |
| Northern Ontario Heritage Fund Corporation | Grant |
| Ontario Centre of Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 44% MoM.
- Aug 3, 2026
Open roles increased to 4, representing 33% of headcount.
For institutional investors. Book with your work email.
Myomar Molecular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myomar Molecular's valuation, stock price, and market status.
Is Myomar Molecular a public or private company?
Myomar Molecular is a private company.
What is the current stock price of Myomar Molecular?
Myomar Molecular is a private company, so its shares have no public market price. Caplight tracks Myomar Molecular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myomar Molecular worth (valuation)?
Valuation information for Myomar Molecular is not publicly available.
Can I buy Myomar Molecular stock?
Myomar Molecular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myomar Molecular's last funding round?
Myomar Molecular's most recent funding round was Seed on May 11, 2026.
Who are the main investors in Myomar Molecular?
Key investors in Myomar Molecular include Northern Ontario Angels.
Will Myomar Molecular IPO soon?
No public IPO plans have been announced for Myomar Molecular.
How can I track Myomar Molecular secondary market activity?
Caplight tracks bids, offers, and trades in Myomar Molecular's shares on secondary markets.